Lumida
/CAI
⌘K
Caris Life Sciences Inc

Caris Life Sciences Inc

CAI
$24.34USD+1.25%+0.30 today

MARKET CAP

6.9B

P/E (TTM)

66.4x

FWD P/E

74.6x

DAY RANGE

$24 – $25

52W RANGE

$14
$35
STATEMENT·Income statement
USD · GAAP
METRICFY 2017FY 2018FY 2019FY 2020FY 2025TREND
Sales, Adj.$315.9M$284.9M$298.9M$294.0M$812.0M
YoY %+7.3%-9.8%+4.9%-1.6%+176.2%
P / Sales1.8x1.6x1.7x1.9x5.6x
EV / Sales7.6x9.6x9.0x8.2x5.2x
Gross Profit, Adj.$247.8M$284.9M$298.9M$294.0M$539.2M
YoY %+2.2%+15.0%+4.9%-1.6%+83.4%
Margin %78.4%100.0%100.0%100.0%66.4%
EV / Gross Profit9.7x9.6x9.0x8.2x7.9x
EBITDA, Adj.$195.2M$247.3M$247.3M$249.7M$67.7M
YoY %+13.1%+26.7%+0.0%+1.0%-72.9%
Margin %61.8%86.8%82.8%84.9%8.3%
EV / EBITDA12.4x11.0x10.9x9.7x62.9x
EBIT$93.1M$140.2M$135.2M$139.1M$45.1M
YoY %+41.2%+50.5%-3.5%+2.9%-67.6%
Margin %29.5%49.2%45.2%47.3%5.6%
EV / EBIT25.9x19.5x19.9x17.3x94.5x
Net Income$72.1M$73.5M$22.2M$18.9M$-538.0M
YoY %+1101.6%+2.0%-69.8%-14.8%-2945.7%
Net Margin22.8%25.8%7.4%6.4%-66.2%
EPS (GAAP)$3.68$3.71$1.23$1.06-$3.22
YoY %+1087.1%+0.8%-66.8%-13.8%-403.8%